Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 21

Showing 21 citing articles:

ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
Oleg Timofeev, Philippe Giron, Steffen Lawo, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
Md Ashiq Mahmud, Abu Bakar Siddique, Afsana Tajmim, et al.
Molecules (2025) Vol. 30, Iss. 1, pp. 139-139
Open Access
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers
Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
A Novel ACVR2A::RAF1 Fusion in Spindle Cell Sarcoma
Anfeng Jiang, Huan Li, Dongbing Li, et al.
Genes Chromosomes and Cancer (2025) Vol. 64, Iss. 2
Closed Access
A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer
Özge Tatlı, Ecenur Cebi, Miray Türk, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
A Comprehensive Review of RAF Kinase: Advances in Inhibition Strategies for Drug Development
Dilay Kahvecioglu
Journal of Molecular Structure (2025), pp. 142206-142206
Closed Access
RAF1 kinase contributes to autophagic lysosome reformation
Stefanie Toifl, Sebastian Didusch, Karin Ehrenreiter, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115490-115490
Open Access
Research progress and applications of epigenetic biomarkers in cancer
Jianjun Gao, Wujiang Shi, Jiangang Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
HRS-4642: The next piece of the puzzle to keep KRAS in check
Alejandra A. Flores-Gómez, Matthias Drosten
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1157-1159
Closed Access | Times Cited: 4
Targeting the Protein-Protein Interaction Between the CDC37 Co-Chaperone and Client Kinases by an Allosteric RAF Dimer Breaker
Alison Yu, Shrhea Banerjee, Sravani Malasani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis
Shuo Wu, Chenxi Hu, Ping Hu, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
SIRT4 as a novel interactor and candidate suppressor of C-RAF kinase in MAPK signaling
Mehrnaz Mehrabipour, Saeideh Nakhaei‐Rad, Radovan Dvorský, et al.
Life Science Alliance (2024) Vol. 7, Iss. 6, pp. e202302507-e202302507
Open Access | Times Cited: 1
Enzyme Is the Name – Adapter Is the Game
Michael Huber, Tilman Brummer
(2024)
Open Access | Times Cited: 1
Exploiting c-RAF dependency in RAS mutant cancer: beyond catalytic activity
Sean F. Cooke, Connor M. Blair
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 3-4, pp. 95-100
Open Access
Phytic acid inhibits RafGOFScrib−/− tumor growth and invasion by suppressing the Yki-mediated JAK/STAT pathway in Drosophila melanogaster
Jin Li, Xinyu Zheng, Chenxi Yu, et al.
Food Bioscience (2024) Vol. 60, pp. 104194-104194
Closed Access
Enhancing oncogenic signaling to kill cancer cells
Amir Noeparast, Oleg Timofeev, Martin Pichler
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 475-477
Open Access
Enzyme Is the Name—Adapter Is the Game
Michael Huber, Tilman Brummer
Cells (2024) Vol. 13, Iss. 15, pp. 1249-1249
Open Access
Novel dual gene fusions identified in a late pulmonary metastasis of an infantile fibrosarcoma-like tumor
Karen E. Schoedel, Shaymaa Hegazy, Megan L Zilla, et al.
Virchows Archiv (2024)
Closed Access
CDK4/6 and SHP2 mediate BRAF/MEK inhibitor resistance in Class 2 and 3 BRAF mutant cancers
April A. N. Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors
Julie Delyon, Selma Becherirat, Anissa Roger, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Structural Insights Into the Impact of the Glycine‐Rich Loop Mutation in Noonan Syndrome on the ATP Binding Pocket of CRAF Kinase
Fatemeh Janati‐Fard, Mohammad Reza Housaindokht, Fatemeh Moosavi, et al.
Proteins Structure Function and Bioinformatics (2024)
Closed Access
Page 1

Scroll to top